Award

Mechanisms for the transactivation of the cyclin A gene by polyomavirus large and small tT antigens

Description: DNA tumorviruses (Adenoviruses and the papovavirus group, papillomavirus, Simian virus 40 and polyoma virus) are DNA viruses with genome sizes between about 5000 and 35000 base pairs. These viruses preferentially infect differentiated, and hence growth arrested cells but require cells in S phase for their replication because they depend almost completely on host replication enzymes for the synthesis of their DNA and many of these enzymes are present in sufficient quantity only in this phase of the cell cycle. These viruses, therefore, encode a few proteins which interfere with the growth regulation of the host cell and allow to drive cells from the quiescent state into the cell cycle. While the evolutionary important role of these viral proteins is their capacity to prepare the permissive host cell for efficient replication of the viral genome, the same activities are also responsible for immortalizing and transforming activities of the tumor viruses in the event of abortive infection of non-perrnissive cells. In case of the mouse virus, polyonia, these activities rest in three early viral proteins, the large, middle and small tumor (T) antigens. We found previously that the large T antigen is capable of transactivating S phase specific enzymes involved in DNA replication and precursor productions but does not itself lead to efficient S phase induction of sertum-starved Swiss 3T3 mouse fibroblasts. lf present together with small T antigen, a significant fraction of cells are driven into S phase. This led us to think about possible candidates for proteins required for S phase induction which are not synthesized in sufficient quantity in response to large T alone. One such protein could be cyclin A which is known to be synthesized at the G1/S border of the cell cycle and to be required for induction and propagation of the S phase. Looking for the synthesis of cyclin A in cells harbouring large T, small T or both proteins, we found that both viral proteins individually are capable of induction of cyclin A in serum starved cells, albeit to a lower degree than addition of serum and also less efficiently than early proteins of other DNA tumorviruses viruses, for instance the E1A protein of adenovirus 5. Both T antigens together cause an effective induction of cyclin A. The promoter sequences of the murine and human cyclin A genes are known but the mechanism of the growth- and cell cycle regulation of this promoter is so far largely unknown. Clarification as to how polyomavirus large and small T antigens transactivate cyclin A will therefore, on the one hand, contribute to our knowledge as to the variety of ways by which products of DNA tumorviruses interfere with events regulating the growth and cell cycle status of cells. lt will, on the other hand, also allow us to investigate the mechanisms by which one decisive step in the control of S phase initiation, the transcription of the cyclin A gene, is regulated in mammalian cells. lt is, consequently, the aim of this proposal to elucidate the mechanisms by which these two viral proteins activate the synthesis of cyclin A, which transcription factors active at the cyclin A promoter are the targets for and which regulatory interactions are disrupted or changed by the viral protein. Towards this goal, the wild type and mutated forms of the murine cyclin A promoter-luciferase constructs will first be employed in cells carrying wild type or mutated versions of the viral proteins. This should allow to define those portions of the promoter involved in transactivation by the viral protein and to determine which amino acid sequences within the viral protein is involved. This should set the stage to define the cellular partners for the viral proteins which play a role in the regulated expression of cyclin A and should further allow us to learn about the mechanism of growth and cell cycle regulation of the cyclin A gene.
Amount: €211,400
Funding type: grant
Funder scheme: Principal Investigator Projects
Start date: 1998-08-01
End date: 2002-12-31
Institutions: University of Vienna, Universität Wien
Subfield: Oncology
Field: Medicine
Funded outputs count: 3
Funder award ID: P13031
OpenAlex ID: G5628837726
2001 · Stefan Schüchner, Maria Nemethova, et al. · Journal of Virology · 13
1999 · Angelika Doetzlhofer, Hans Rotheneder, et al. · Molecular and Cellular Biology · 402